Mammalian Genome

, Volume 9, Issue 10, pp 794–798

A major quantitative trait locus co-localizing with cholecystokinin type A receptor gene influences poor pancreatic proliferation in a spontaneously diabetogenic rat

  • Daniel H.  Moralejo
  • Tomoe  Ogino
  • Min  Zhu
  • Kiyotaka  Toide
  • Suwen  Wei
  • Kaichun  Wei
  • Takahisa  Yamada
  • Akira  Mizuno
  • Kozo  Matsumoto
  • Kenji  Shima

DOI: 10.1007/s003359900869

Cite this article as:
Moralejo, D., Ogino, T., Zhu, M. et al. (1998) 9: 794. doi:10.1007/s003359900869

Abstract.

The Otsuka Long-Evans Tokushima Fatty (OLETF) rat is an animal model for obese-type, non-insulin-dependent diabetes mellitus (NIDDM) in humans. The OLETF rat has poor capacity for pancreatic proliferation, which may be the critical pathogenetic event in NIDDM development. Our investigation was designed to identify quantitative trait loci (QTLs) responsible for poor pancreatic proliferation by examining compensatory proliferation of the pancreatic remnant after partial pancreatectomy and performing a genome-wide scan in an F2 intercross obtained by mating the OLETF and the Fischer-344 (F344) rats. We identified a highly significant QTL on rat Chromosome 14 with a maximum lod score of 16.7, which accounts for 55% of the total variance. The QTL co-localizes with the gene encoding cholecystokinin type A receptor (CCKAR) which is likely to mediate the trophic effect of cholecystokinin on pancreas and is defective in the OLETF rat.

Copyright information

© Springer-Verlag New York Inc. 1998

Authors and Affiliations

  • Daniel H.  Moralejo
    • 1
  • Tomoe  Ogino
    • 1
  • Min  Zhu
    • 2
  • Kiyotaka  Toide
    • 3
  • Suwen  Wei
    • 1
  • Kaichun  Wei
    • 1
  • Takahisa  Yamada
    • 1
  • Akira  Mizuno
    • 2
  • Kozo  Matsumoto
    • 1
  • Kenji  Shima
    • 2
  1. 1.Institute for Animal Experimentation, University of Tokushima School of Medicine, Kuramoto, Tokushima 770, JapanJP
  2. 2.Department of Laboratory Medicine, University of Tokushima School of Medicine, Kuramoto, Tokushima 770, JapanJP
  3. 3.Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd, Tokushima 771, JapanJP

Personalised recommendations